Subjects
head tumors, migraine, MR, head trauma, diabetes
MIGRAINE, HYPERTENSION, CHRONIC DISEASES, DIABETES
This trial was approved by the institutional review board of Shuguang Hospital, affiliated with Shanghai University of Traditional Chinese Medicine (NO. 2017‐570‐53‐01) in accordance with the Declaration of Helsinki. This trial was registered in the Chinese Clinical Trial Registry (ChiCTR1800015692). All participants signed informed consent.Sixty healthy individuals were recruited through advertisements for this trial at a male:female ratio of 1:1. The inclusion criteria for participants were as follows: (1) right‐handed; (2) age from 20 to 40 years; (3) healthy history; (4) no medication or acupuncture treatment one month prior to this trial; and (5) understanding of this trial and signing the informed consent form.The exclusion criteria for participants were as follows: (1) left‐handed; (2) a history of chronic diseases, such as hypertension, diabetes, and migraine; (3) medication or acupuncture treatment one month prior to this trial; (4) fear of accepting acupuncture intervention; (5) contradictions for MR examination; (6) pregnancy; and (7) a history of head tumors or head trauma.